These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 5340324)

  • 21. Irreversible enzyme inhibitors. CXII. Active-site-directed irreversible inhibitors of dihydrofolic reductase derived from 4,6-diamino-1,2-dihydro-2,2-dimethyl-1-phenyl-s-triazine substituted with a terminal sulfonyl fluoride. II.
    Baker BR; Lourens GJ
    J Med Chem; 1968 Jan; 11(1):38-41. PubMed ID: 5237173
    [No Abstract]   [Full Text] [Related]  

  • 22. Irrevesible enzyme inhibitors. CLI. Active-site-directed irreversible inhibitors of dihydrofolic reductase derived from 5-(p-aminophenylbutyl)-2,4-diaminopyrimidines with a terminal sulfonyl fluoride.
    Baker BR; Meyer RB
    J Med Chem; 1969 Mar; 12(2):224-7. PubMed ID: 5254099
    [No Abstract]   [Full Text] [Related]  

  • 23. Irreversible enzyme inhibitors. CLVII. Effect of bridge modification on the selective irreversible inhibition of dihydrofolic reductase from L1210 mouse leukemia and liver by 2,4-diamino-5-(3,4-dichlorophenyl)-6-[p-(m-fluorosulfonylbenzamidomethyl)phenoxymethyl]pyrimidine. I.
    Baker BR; Vermeulen NM
    J Med Chem; 1969 Jul; 12(4):680-4. PubMed ID: 5793161
    [No Abstract]   [Full Text] [Related]  

  • 24. Irreversible enzyme inhibitors. CLVII. Effect of bridge modification on the selective irreversible inhibition of dihydrofolic reductase from L1210 mouse leukemia and liver by 2,4-diamino-5-(3,4-dichlorophenyl)-6-[p-(m-fluorosultonyl-benzamidomethyl) phenozymethyl]pyrimidine. I.
    Baker BR; Vermeulen NM
    J Med Chem; 1969 Jul; 12(4):680-4. PubMed ID: 5822623
    [No Abstract]   [Full Text] [Related]  

  • 25. Isoelectric focusing studies on dihydrofolic reductase.
    Kaufman BT
    Ann N Y Acad Sci; 1971 Nov; 186():100-6. PubMed ID: 4399846
    [No Abstract]   [Full Text] [Related]  

  • 26. Studies on dihydrofolic reductase, II. The activation of dihydrofolic reductase from chicken liver by iodine.
    Kaufman BT
    Proc Natl Acad Sci U S A; 1966 Aug; 56(2):695-700. PubMed ID: 4381832
    [No Abstract]   [Full Text] [Related]  

  • 27. Insights into the slow-onset tight-binding inhibition of Escherichia coli dihydrofolate reductase: detailed mechanistic characterization of pyrrolo [3,2-f] quinazoline-1,3-diamine and its derivatives as novel tight-binding inhibitors.
    Srinivasan B; Skolnick J
    FEBS J; 2015 May; 282(10):1922-38. PubMed ID: 25703118
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Characterization of the cloned Escherichia coli dihydrofolate reductase.
    Rood JI; Williams JW
    Biochim Biophys Acta; 1981 Aug; 660(2):214-8. PubMed ID: 6269632
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Structure-activity analysis of tetrahydrofolate analogs using sutstituent constants and regression analysis.
    Miller E; Hansch C
    J Pharm Sci; 1967 Jan; 56(1):92-7. PubMed ID: 6030502
    [No Abstract]   [Full Text] [Related]  

  • 30. Mechanism of inhibition of wt-dihydrofolate reductase from E. coli by tea epigallocatechin-gallate.
    Spina M; Cuccioloni M; Mozzicafreddo M; Montecchia F; Pucciarelli S; Eleuteri AM; Fioretti E; Angeletti M
    Proteins; 2008 Jul; 72(1):240-51. PubMed ID: 18214969
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Dihydrofolate reductase from Trypanosoma equiperdum. II. Inhibition by 2,4-diaminopyrimidines and related heterocycles.
    McCormack JJ; Jaffe JJ
    J Med Chem; 1969 Jul; 12(4):662-8. PubMed ID: 5793158
    [No Abstract]   [Full Text] [Related]  

  • 32. In vivo measurement of dihydrofolate reductase and its inhibition by antifolates.
    Bowers SW; Duch DS
    Anal Biochem; 1988 Jul; 172(1):169-75. PubMed ID: 3189762
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Structure-based design and synthesis of lipophilic 2,4-diamino-6-substituted quinazolines and their evaluation as inhibitors of dihydrofolate reductases and potential antitumor agents.
    Gangjee A; Vidwans AP; Vasudevan A; Queener SF; Kisliuk RL; Cody V; Li R; Galitsky N; Luft JR; Pangborn W
    J Med Chem; 1998 Aug; 41(18):3426-34. PubMed ID: 9719595
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Purification and properties of 5,10-methylenetetrahydrofolate dehydrogenase from Escherichia coli.
    Donaldson KO; Scott VF; Scott W
    J Biol Chem; 1965 Nov; 240(11):4444-8. PubMed ID: 4378935
    [No Abstract]   [Full Text] [Related]  

  • 35. 2,4-Diamino-6,7-dihydro-5H-cyclopenta[d]pyrimidine analogues of trimethoprim as inhibitors of Pneumocystis carinii and Toxoplasma gondii dihydrofolate reductase.
    Rosowsky A; Papoulis AT; Queener SF
    J Med Chem; 1998 Mar; 41(6):913-8. PubMed ID: 9526565
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Analogs of tetrahydrofolic acid. 32. Hydrophobic bonding to dihydrofolic reductase IV. Inhibition by p-substituted benzoic and benzoyl-L-glutamic acids.
    Baker BR; Schwan TJ; Novotny J; Ho BT
    J Pharm Sci; 1966 Mar; 55(3):295-302. PubMed ID: 5960175
    [No Abstract]   [Full Text] [Related]  

  • 37. The "induction" of leukocyte and erythrocyte dihydrofolate reductase by methotrexate. II. Clinical and pharmacologic studies.
    Bertino JR; Cashmore A; Fink M; Calabresi P; Lefkowitz E
    Clin Pharmacol Ther; 1965; 6(6):763-70. PubMed ID: 5846409
    [No Abstract]   [Full Text] [Related]  

  • 38. Dihydrofolate reductase from guinea pig liver and small intestine.
    Bertino JR; Iannotti AT; Perkins JP; Johns DG
    Biochem Pharmacol; 1966 May; 15(5):563-71. PubMed ID: 5227348
    [No Abstract]   [Full Text] [Related]  

  • 39. Comparative biochemistry of dihydrofolate reductase.
    Burchall JJ
    Ann N Y Acad Sci; 1971 Nov; 186():143-52. PubMed ID: 4943573
    [No Abstract]   [Full Text] [Related]  

  • 40. Inhibition of Pneumocystis carinii, Toxoplasma gondii, and Mycobacterium avium dihydrofolate reductases by 2,4-diamino-5-[2-methoxy-5-(omega-carboxyalkyloxy)benzyl]pyrimidines: marked improvement in potency relative to trimethoprim and species selectivity relative to piritrexim.
    Rosowsky A; Forsch RA; Queener SF
    J Med Chem; 2002 Jan; 45(1):233-41. PubMed ID: 11754594
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.